IncFact
Company Profiles: Revenue, Growth, Competition

Ascent Pharmaceuticals Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Ascent Pharmaceuticals

Access the complete profile.

Ascent Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address400 South Technology Drive
Central Islip, NY 11722

Note: Revenues for privately held companies are statistical evaluations.


Ascent Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Ascent Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Ascent Pharmaceuticals Annual Revenue and Growth Rate

Ascent Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Ascent Pharmaceuticals's revenues are gauged from an analysis of company filings.



Ascent Pharmaceuticals's Income Statement (based on Industry Averages)

Ascent Pharmaceuticals P&L$ Millions
Revenue (Sales) Ascent Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Ascent Pharmaceuticals is developing and marketing. Ascent Pharmaceuticals doesn't have any recent trademark applications, indicating Ascent Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ASCENT
Pharmaceutical preparations for human use, namely, central nervous system (CNS) stimulants
09/15/2016

See all trademarks and details in the Full Report.


Market Share of Ascent Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ascent Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Ascent Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
L.N.K. INTERNATIONALHauppauge, NY100 
PIPING ROCK HEALTH PRODUCTSBohemia, NY50 
BACTOLAC PHARMACEUTICALHauppauge, NY38 
TOPIDERMAmityville, NY37 
CONTRACT PHARMACALHauppauge, NY25 
ASCENT PHARMACEUTICALSCentral Islip, NY17 




Future Competition: Ascent Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ascent Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ascent Pharmaceuticals Competitors